Posts by Daniel L. Faden, MD, FACS
-
Knowledge That HPV Can Cause Oropharyngeal Cancer Increases Likelihood of Vaccination
Daniel L. Faden, MD, FACS,and colleagues found only 23% of clinic patients knew there's a relationship between human papillomavirus virus (HPV) infection and oropharyngeal cancer (OPSCC), but those who did know were 3.7 times more likely to be vaccinated against HPV.
-
Fighting HPV Head and Neck Cancer One Blood Sample At a Time
The incidence of HPV-associated head and neck cancers has become an epidemic in the U.S. Recent studies at Mass Eye and Ear reveal that non-invasive "liquid biopsies" might revolutionize the way surgeons diagnose and treat the disease for years to come.
-
HPV-Associated Head and Neck Cancer Blood Test Shows Promise as Test to Replace Tissue Biopsy
A liquid biopsy test developed in the lab of Mass Eye and Ear researcher Dan Faden, MD, FACS, was more accurate, potentially faster and less costly than standard clinical workup for diagnosing HPV-associated head and neck cancer.
Biography
Daniel L. Faden, MD, FACS, is a head and neck surgical oncologist and investigator in the Mike Toth Head and Neck Cancer Research Center at Mass Eye and Ear and an assistant professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School.
Mass Eye and Ear/Mass General Otolaryngology–Head and Neck Surgery
A teaching hospital of Harvard Medical School, Mass Eye and Ear/Massachusetts General Hospital combines the expertise of highly specialized ear, nose, and throat physicians, audiologists, speech-language pathologists and auxiliary health care professionals to provide care for patients with problems affecting the ear, nose, throat, head and neck areas. The department, which is led by Chief and Chair Mark A. Varvares, MD, FACS, is one of the largest otolaryngology–head and neck surgery (OHNS) departments in the country, with more than 70 physicians staffed at 15 locations in the greater Boston area.
